Infusion of dexmedetomidine and magnesium sulfate on the stability of hemodynamic status

Comparison of dexmedetomidine and magnesium sulfate infusion on the stability of hemodynamic status during orthopedic surgery in obese people

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190325043107N46

Enrollment

160

Registered

2024-05-03

Start date

2021-01-01

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamic status. Complications of internal orthopedic prosthetic devices, implants and grafts

Interventions

Intervention 1: Intervention group: This group will be made up of obese people. These patients will receive an infusion of half a microgram per kilogram per hour half an hour before surgery, and their

Eligibility

Sex/Gender

All

Age

40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Candidate for orthopedic surgery Consent to participate in the research project

Exclusion criteria

Exclusion criteria: Allergy to study drugs Hemodynamic status changes during anesthesia more than 30%

Design outcomes

Primary

Measure	Time frame
Hemodynamic status. Timepoint: From three minutes before surgery to the first half hour of surgery, once every three minutes. Method of measurement: Monitoring and measurement of hemodynamic status.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Khanbabayi Gol

Tabriz University of Medical Sciences

Khanbabayimehdi69@gmail.com+98 41 3334 7054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026